It was really quite sad to hear that we recruited 7 patients but couldn't enroll them in the study because we were focused on EMD. Imagine the data we could have collected and also the lives that could have been impacted.
I saw this train wreck coming a mile away after the absolutely stupid decision to drop the EMD AML trial and thereby not have any clinical trials running until RC220 was up an running mid to late next year.
Any smart operator who cared about the SP would have seen that the market didn't really give two hoots about our outstanding preclinical results and the only thing that would have propped up the SP would have been results from clinical trials run by us. As John rightly said RC110 would have invalidated most of the markets concern.
As much as@Davisite wants us to keep calm and carry forward , I have to admire@johndprent persistence in ensuring that sins of the past are not forgotten.
It was really quite sad to hear that we recruited 7 patients but...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
-0.030(2.46%) |
Mkt cap ! $197.8M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.24 | $1.17 | $25.43K | 21.19K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 700 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 2856 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.19 |
Change
-0.030 ( 1.25 %) |
||||
| Open | High | Low | Volume | ||
| $1.18 | $1.24 | $1.18 | 8334 | ||
| Last updated 15.37pm 06/05/2024 ? | |||||
| RAC (ASX) Chart |